GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (XCNQ:TRUL) » Definitions » Change In Payables And Accrued Expense

Trulieve Cannabis (XCNQ:TRUL) Change In Payables And Accrued Expense : C$283 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis Change In Payables And Accrued Expense?

Trulieve Cannabis's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was C$137 Mil. It means Trulieve Cannabis's Accounts Payable & Accrued Expense increased by C$137 Mil from Dec. 2023 to Mar. 2024 .

Trulieve Cannabis's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was C$153 Mil. It means Trulieve Cannabis's Accounts Payable & Accrued Expense increased by C$153 Mil from Dec. 2022 to Dec. 2023 .


Trulieve Cannabis Change In Payables And Accrued Expense Historical Data

The historical data trend for Trulieve Cannabis's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis Change In Payables And Accrued Expense Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.02 -2.76 -25.46 43.11 152.55

Trulieve Cannabis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.65 -79.26 11.79 213.39 137.15

Trulieve Cannabis Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$283 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trulieve Cannabis Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis (XCNQ:TRUL) Business Description

Industry
Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.

Trulieve Cannabis (XCNQ:TRUL) Headlines

From GuruFocus

Trulite Inc (TRUL) President and CEO Kim A. Rivers Bought $97,936 of Shares

By GuruFocus Research GuruFocus Editor 08-18-2021

Trulite Inc (TRUL) President and CEO Kim A. Rivers Bought $1 million of Shares

By GuruFocus Research GuruFocus Editor 06-16-2021

Is Trulite Inc Undervalued Following the Latest Insider Buy?

By GuruFocus Research GuruFocus Editor 05-26-2022